<i>Salmonella</i> produces sulfide to compete with <i>Escherichia coli</i> in the gut lumen
Abstract
Hydrogen sulfide production is a characteristic that distinguishes Salmonella serovars from closely related species, such as Escherichia coli , but its biological significance remains obscure. Here, we show that PhsABC and AsrABC-mediated hydrogen sulfide production by Salmonella enterica serovar ( S. ) Typhimurium was linked to an increased abundance of Deltaproteobacteria and inhibition of cytochrome bd oxidase-mediated aerobic respiration of Escherichia coli in the murine large intestine. Functional phsABC and asrABC operons provided a growth benefit to S. Typhimurium in the cecum of Enterobacterales- free conventional mice only upon inoculation with commensal E. coli. In gnotobiotic mice engrafted with a defined community of 17 human Clostridia isolates, S. Typhimurium infection inhibited cytochrome bd oxidase-mediated aerobic respiration in E. coli only in the presence of Desulfovibrio piger , a sulfide-producing representative of the Deltaproteobacteria. A S. Typhimurium strain deficient for hydrogen sulfide production ( phsA asrA mutant) did not inhibit cytochrome bd oxidase-mediated aerobic respiration in E. coli , even when D. piger was present. Collectively, these data suggest that the phsABC and asrABC operons of Salmonella serovars provide a benefit during competition with closely related bacteria, such as E. coli , by inhibiting cytochrome bd oxidase-mediated aerobic respiration of the commensal.
Article Details
Journal Info
Proceedings of the National Academy of Sciences
National Academy of Sciences
Authors (10)
Anaïs B. Larabi
Department of Medical Microbiology and Immunology, School of Medicine, University of California
Connor R. Tiffany
Department of Medical Microbiology and Immunology, School of Medicine, University of California
Hugo L. P. Masson
Department of Medical Microbiology and Immunology, School of Medicine, University of California
Henry Nguyen
Department of Medical Microbiology and Immunology, School of Medicine, University of California
Eli J. Bejarano
Department of Medical Microbiology and Immunology, School of Medicine, University of California
Megan J. Liou
Department of Medical Microbiology and Immunology, School of Medicine, University of California
Lauren C. Radlinski
Department of Medical Microbiology and Immunology, School of Medicine, University of California
Aurore M. Demars
Department of Medical Microbiology and Immunology, School of Medicine, University of California
Renée M. Tsolis
Department of Medical Microbiology and Immunology, School of Medicine, University of California
Andreas J. Bäumler
Department of Medical Microbiology and Immunology, School of Medicine, University of California